Literature DB >> 10190999

Speech timing subsequent to brain damage: effects of utterance length and complexity.

S R Baum1, J P Boyczuk.   

Abstract

Acoustic analyses of syllable durations were conducted in order to address several hypotheses concerning deficits in the control of speech timing subsequent to focal brain damage. Groups of nonfluent and fluent aphasics, right-hemisphere-damaged patients, and normal controls produced monosyllabic root syllables in medial and final position in the context of short and long sentences and syntactically simple and complex sentences. Durations of the target syllable as a proportion of the utterance were compared across contexts and groups. Somewhat surprisingly, the results revealed relatively normal temporal patterns in all subject groups, with the main exception emerging for the nonfluent aphasic patients who failed to demonstrate normal phrase-final lengthening effects. Implications of the findings for theories of temporal control in brain-damaged patients are considered. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10190999     DOI: 10.1006/brln.1999.2047

Source DB:  PubMed          Journal:  Brain Lang        ISSN: 0093-934X            Impact factor:   2.381


  3 in total

1.  The efficacy of a directed rhythmic-melodic voice training in the treatment of chronic non-fluent aphasia-Behavioral and imaging results.

Authors:  Monika Jungblut; Christiane Mais; Ferdinand Christoph Binkofski; André Schüppen
Journal:  J Neurol       Date:  2022-05-23       Impact factor: 6.682

2.  Prosodic changes in aphasic speech: timing.

Authors:  Diana Van Lancker Sidtis; Daniel Kempler; Catherine Jackson; E Jeffrey Metter
Journal:  Clin Linguist Phon       Date:  2010-02       Impact factor: 1.346

3.  Paving the way for speech: voice-training-induced plasticity in chronic aphasia and apraxia of speech--three single cases.

Authors:  Monika Jungblut; Walter Huber; Christiane Mais; Ralph Schnitker
Journal:  Neural Plast       Date:  2014-05-25       Impact factor: 3.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.